(Q39682990)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

J B Weinberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

M N Kennedy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

K M Bond

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

J O Moore

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

M C Lanasa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

J P Gockerman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

L F Diehl

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

S V Pizzo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

G J Cianciolo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

D R Friedman

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

8 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

1580-1587

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613784%20AND%20SRC:MED&resulttype=core&format=json

Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Infectious complications of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Treatment of experimental colitis in mice with LMP-420, an inhibitor of TNF transcription

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

LMP-420, a small-molecule inhibitor of TNF-alpha, reduces replication of HIV-1 and Mycobacterium tuberculosis in human cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein Enbrel in patients with refractory hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Genomic aberrations and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Adjusting batch effects in microarray expression data using empirical Bayes methods

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

GATHER: a systems approach to interpreting genomic signatures

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Cell death: the significance of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Human cytokines suppress apoptosis of leukaemic CD5+ B cells and preserve expression of bcl-2

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Influence of CD40 ligation on survival and apoptosis of B-CLL cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

The hematopoiesis-specific GTP-binding protein RhoH is GTPase deficient and modulates activities of other Rho GTPases by an inhibitory function

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Autophagy suppresses tumorigenesis through elimination of p62

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

NF-kappaB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Pharmacological inhibitors of NF-κB accelerate apoptosis in chronic lymphocytic leukaemia cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2'-deoxyadenosine

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021

Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.150

7 January 2021